Rare diseases 2030: how augmented AI will support diagnosis and treatment of rare diseases in the future.

Abstract

Authors

• Martin Christian Hirsch
  Institute for AI in Medicine, University Hospital of Giessen and Marburg, Marburg, Germany.
• Simon Ronicke
  Ada Health GmbH, Berlin, Germany.
• Martin Krusche
  Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
• Annette Doris Wagner
  Department of Nephrology, Hannover Medical School, Hannover, Germany Wagner.Annette@mh-hannover.de.

Keywords

External Resources